[(2S,3R,4S,6R)-2-[[(1R,2S,3R,6R,8R,9R,10R,13E,16R,18R)-17-acetylimino-13-[(2-amino-1,3-benzoxazol-5-yl)methoxyimino]-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-4-oxabicyclo[8.5.4]nonadecan-9-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate

C46H69N5O11 — CID 172932174

IUPAC[(2S,3R,4S,6R)-2-[[(1R,2S,3R,6R,8R,9R,10R,13E,16R,18R)-17-acetylimino-13-[(2-amino-1,3-benzoxazol-5-yl)methoxyimino]-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-4-oxabicyclo[8.5.4]nonadecan-9-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate
SMILESCC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2OC(C)=O)[C@]2(C)CC/C(=N/OCc3ccc4oc(N)nc4c3)CC[C@H]([C@@H](C)/C(=N\C(C)=O)[C@H](C)C2)[C@]1(C)O
InChIInChI=1S/C46H69N5O11/c1-13-37-46(10,56)33-16-15-32(50-57-23-31-14-17-36-34(21-31)49-44(47)60-36)18-19-45(9,22-24(2)38(26(33)4)48-29(7)52)41(27(5)39(54)28(6)42(55)61-37)62-43-40(59-30(8)53)35(51(11)12)20-25(3)58-43/h14,17,21,24-28,33,35,37,40-41,43,56H,13,15-16,18-20,22-23H2,1-12H3,(H2,47,49)/b48-38-,50-32+/t24-,25-,26-,27+,28-,33-,35+,37-,40-,41-,43+,45-,46+/m1/s1
InChIKeySIXLQOSCPCNLIR-NXEWNKGDSA-N
MW868.08 g/mol
LogP6.44
Rot. Bonds8

About [(2S,3R,4S,6R)-2-[[(1R,2S,3R,6R,8R,9R,10R,13E,16R,18R)-17-acetylimino-13-[(2-amino-1,3-benzoxazol-5-yl)methoxyimino]-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-4-oxabicyclo[8.5.4]nonadecan-9-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate

[(2S,3R,4S,6R)-2-[[(1R,2S,3R,6R,8R,9R,10R,13E,16R,18R)-17-acetylimino-13-[(2-amino-1,3-benzoxazol-5-yl)methoxyimino]-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-4-oxabicyclo[8.5.4]nonadecan-9-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate (PubChem CID 172932174) has the molecular formula C46H69N5O11 and a molecular weight of 868.08 g/mol. Its IUPAC name is [(2S,3R,4S,6R)-2-[[(1R,2S,3R,6R,8R,9R,10R,13E,16R,18R)-17-acetylimino-13-[(2-amino-1,3-benzoxazol-5-yl)methoxyimino]-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-4-oxabicyclo[8.5.4]nonadecan-9-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate.

Molecular Properties

Compound Name[(2S,3R,4S,6R)-2-[[(1R,2S,3R,6R,8R,9R,10R,13E,16R,18R)-17-acetylimino-13-[(2-amino-1,3-benzoxazol-5-yl)methoxyimino]-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-4-oxabicyclo[8.5.4]nonadecan-9-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate
PubChem CID172932174
Molecular FormulaC46H69N5O11
Molecular Weight868.08 g/mol
Exact Mass867.50
IUPAC Name[(2S,3R,4S,6R)-2-[[(1R,2S,3R,6R,8R,9R,10R,13E,16R,18R)-17-acetylimino-13-[(2-amino-1,3-benzoxazol-5-yl)methoxyimino]-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-4-oxabicyclo[8.5.4]nonadecan-9-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate
SMILESCC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2OC(C)=O)[C@]2(C)CC/C(=N/OCc3ccc4oc(N)nc4c3)CC[C@H]([C@@H](C)/C(=N\C(C)=O)[C@H](C)C2)[C@]1(C)O
InChIInChI=1S/C46H69N5O11/c1-13-37-46(10,56)33-16-15-32(50-57-23-31-14-17-36-34(21-31)49-44(47)60-36)18-19-45(9,22-24(2)38(26(33)4)48-29(7)52)41(27(5)39(54)28(6)42(55)61-37)62-43-40(59-30(8)53)35(51(11)12)20-25(3)58-43/h14,17,21,24-28,33,35,37,40-41,43,56H,13,15-16,18-20,22-23H2,1-12H3,(H2,47,49)/b48-38-,50-32+/t24-,25-,26-,27+,28-,33-,35+,37-,40-,41-,43+,45-,46+/m1/s1
InChIKeySIXLQOSCPCNLIR-NXEWNKGDSA-N
XLogP6.44
TPSA214.67 Ų
H-Bond Donors2
H-Bond Acceptors15
Rotatable Bonds8
Heavy Atoms62
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500868.08
LogP ≤ 56.44
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze [(2S,3R,4S,6R)-2-[[(1R,2S,3R,6R,8R,9R,10R,13E,16R,18R)-17-acetylimino-13-[(2-amino-1,3-benzoxazol-5-yl)methoxyimino]-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-4-oxabicyclo[8.5.4]nonadecan-9-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2S,3R,4S,6R)-2-[[(1R,2S,3R,6R,8R,9R,10R,13E,16R,18R)-17-acetylimino-13-[(2-amino-1,3-benzoxazol-5-yl)methoxyimino]-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-4-oxabicyclo[8.5.4]nonadecan-9-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate?
The IUPAC name of [(2S,3R,4S,6R)-2-[[(1R,2S,3R,6R,8R,9R,10R,13E,16R,18R)-17-acetylimino-13-[(2-amino-1,3-benzoxazol-5-yl)methoxyimino]-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-4-oxabicyclo[8.5.4]nonadecan-9-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate (CID 172932174) is [(2S,3R,4S,6R)-2-[[(1R,2S,3R,6R,8R,9R,10R,13E,16R,18R)-17-acetylimino-13-[(2-amino-1,3-benzoxazol-5-yl)methoxyimino]-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-4-oxabicyclo[8.5.4]nonadecan-9-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate.
What is the SMILES notation for [(2S,3R,4S,6R)-2-[[(1R,2S,3R,6R,8R,9R,10R,13E,16R,18R)-17-acetylimino-13-[(2-amino-1,3-benzoxazol-5-yl)methoxyimino]-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-4-oxabicyclo[8.5.4]nonadecan-9-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate?
The canonical SMILES for [(2S,3R,4S,6R)-2-[[(1R,2S,3R,6R,8R,9R,10R,13E,16R,18R)-17-acetylimino-13-[(2-amino-1,3-benzoxazol-5-yl)methoxyimino]-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-4-oxabicyclo[8.5.4]nonadecan-9-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate is CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2OC(C)=O)[C@]2(C)CC/C(=N/OCc3ccc4oc(N)nc4c3)CC[C@H]([C@@H](C)/C(=N\C(C)=O)[C@H](C)C2)[C@]1(C)O.
What is the InChIKey of [(2S,3R,4S,6R)-2-[[(1R,2S,3R,6R,8R,9R,10R,13E,16R,18R)-17-acetylimino-13-[(2-amino-1,3-benzoxazol-5-yl)methoxyimino]-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-4-oxabicyclo[8.5.4]nonadecan-9-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate?
The InChIKey is SIXLQOSCPCNLIR-NXEWNKGDSA-N. The full InChI is InChI=1S/C46H69N5O11/c1-13-37-46(10,56)33-16-15-32(50-57-23-31-14-17-36-34(21-31)49-44(47)60-36)18-19-45(9,22-24(2)38(26(33)4)48-29(7)52)41(27(5)39(54)28(6)42(55)61-37)62-43-40(59-30(8)53)35(51(11)12)20-25(3)58-43/h14,17,21,24-28,33,35,37,40-41,43,56H,13,15-16,18-20,22-23H2,1-12H3,(H2,47,49)/b48-38-,50-32+/t24-,25-,26-,27+,28-,33-,35+,37-,40-,41-,43+,45-,46+/m1/s1.
What are the key properties of [(2S,3R,4S,6R)-2-[[(1R,2S,3R,6R,8R,9R,10R,13E,16R,18R)-17-acetylimino-13-[(2-amino-1,3-benzoxazol-5-yl)methoxyimino]-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-4-oxabicyclo[8.5.4]nonadecan-9-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate?
[(2S,3R,4S,6R)-2-[[(1R,2S,3R,6R,8R,9R,10R,13E,16R,18R)-17-acetylimino-13-[(2-amino-1,3-benzoxazol-5-yl)methoxyimino]-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-4-oxabicyclo[8.5.4]nonadecan-9-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate has a molecular weight of 868.08 g/mol, XLogP of 6.44, 8 rotatable bonds, 2 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for [(2S,3R,4S,6R)-2-[[(1R,2S,3R,6R,8R,9R,10R,13E,16R,18R)-17-acetylimino-13-[(2-amino-1,3-benzoxazol-5-yl)methoxyimino]-3-ethyl-2-hydroxy-2,6,8,10,16,18-hexamethyl-5,7-dioxo-4-oxabicyclo[8.5.4]nonadecan-9-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate is sourced from PubChem (CID 172932174), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).